• Hyperargininemia due to liver arginase deficiency. (medlineplus.gov)
  • Using directed molecular evolution coupled with high throughput genetic selections and screening strategies, Stone's group has successfully engineered several therapeutic enzyme technologies that are advancing to the clinic, including an engineered human arginase for cancer therapy and for treatment of hyperargininemia. (utexas.edu)